Can-Fite BioPharma Ltd. - American Depositary Receipt logo

Can-Fite BioPharma Ltd. - American Depositary Receipt (CANF)

Market Closed
27 Jul, 20:00
AMEX AMEX
$
3. 15
-0.04
-1.2539%
$
1.82M Market Cap
- P/E Ratio
0.68% Div Yield
20,293 Volume
- Eps
$ 3.19
Previous Close
Investors:
Add Transaction
Day Range
3.15 3.25
Year Range
2.56 20
Want to track CANF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Can-Fite BioPharma Ltd. - American Depositary Receipt (CANF) Statistics

Valuation metrics

Market Cap 1.82M
Enterprise value 8.48B
Trailing P/E (ttm) -0.72
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 20,960.93
Price/Book (mrq) 0.64
Enterprise Value/Revenue 20,947.45
Enterprise Value/EBITDA -854.7

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 61.75K
Average volume (90 days) 3.27M

Price summary

52-Week low 2.56
52-Week high 20
Beta -
50-Day moving average 3.27
200-Day moving average 3.69

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 5 Jan 2026

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -24.27%
Operating margin -24.57%

Operational effectiveness

Return on assets -1.03%
Return on equity -2.01%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 56.38
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1,368.09
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1,188.79
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 3.46%
Book value per share (mrq) 778.42

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -